Clinical Trial Update: Study on the Short-term Efficacy and Safety of Recombinant Human Thrombopoietin Combined With Immunosuppressant Sequential Eltrombopag Ethanolamine Dry Suspension in the Treatment of SAA/TD-NSAA [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating short-term efficacy and safety of combining recombinant human thrombopoietin with sequential eltrombopag ethanolamine dry susp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Eltrombopag Ethanolamine Dry Suspension (eltrombopag)
• recombinant human thrombopoietin (recombinant human thrombopoietin)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Aplastic Anemias | Phase 3 | Status: NOT_YET_RECRUITING